Surgeon General report highlights strategies to prevent, treat OUDs

Sep 20, 2018 - 02:53 PM
surgeon-general-opioids-hero

U.S. Surgeon General Jerome Adams today released a report highlighting actions individuals and families, health care providers, educators, employers, researchers and communities can take to prevent and treat opioid use disorders and reduce overdose deaths. Created with the Substance Abuse and Mental Health Services Administration, the report combines opioid-related information from the 2016 “Surgeon General’s Report on Alcohol, Drugs and Health” with updated data on the prevalence of OUDs and related harms. “Now is the time to work together and apply what we know to end the opioid crisis,” said Elinore McCance-Katz, M.D., assistant secretary for mental health and substance use at the Department of Health and Human Services. “Medication-assisted treatment combined with psychosocial therapies and community-based recovery supports is the gold standard for treating opioid addiction.” For more on the report and associated federal resources, visit https://addiction.surgeongeneral.gov.

Related News Articles

Headline
Study finds AI screening for OUD led to fewer hospital readmissions 
The National Institutes of Health April 3 released a study that found an artificial intelligence screening tool was as effective as health care providers in…
Headline
HHS extends public health emergency for opioid crisis
The Department of Health and Human Services March 18 announced that it renewed the public health emergency for the nation’s opioid crisis an additional 90 days…
Headline
OIG report finds just 40% of Medicare enrollees who started treatment for opioid use disorder continued
The Department of Health and Human Services Office of Inspector General Feb. 18 released a report that found about 40% of Medicare enrollees who began opioid…
Headline
DEA and HHS delay implementation of buprenorphine final rule
Today the Drug Enforcement Administration and Department of Health and Human Services announced that the effective date for the final rule regarding…
Headline
FDA approves first-in-class non-opioid painkiller 
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
AHA podcast: Englewood Health's Strategies to Combat Rising Opioid Use in Post-Pandemic America
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…